|
|
Blood, 1 March 2007, Vol. 109, No. 5, pp. 2023-2031.
Prepublished online as a Blood First Edition Paper on October 31, 2006; DOI 10.1182/blood-2006-05-021600.
Previous Article | Next Article 
Submitted May 9, 2006
Accepted October 10, 2006
IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo
Anja Frohlich, Benjamin J Marsland, Ivo Sonderegger, Michael Kurrer, Martin R Hodge, Nicola L Harris, and Manfred Kopf*
Institute of Integrative Biology, Molecular Biomedicine, ETH Zurich, Switzerland
Dept of Pathology, University Zurich, Switzerland
Inflammation Division, Millenium Pharmaceuticals, Inc., Cambridge, MA, United States
Institute of Integrative Biology, Environmental Biomedicine, ETH Zurich, Switzerland
* Corresponding author; email: manfred.kopf{at}ethz.ch.
Interleukin 21 (IL-21) is a member of the common -chain family of cytokines, which influence a broad spectrum of immunological responses. A number of studies have examined the function of IL-21; however, its specific role in Th1/ Th2 cell differentiation and related effector responses remains to be clarified. Thus, we generated IL-21R-deficient mice and have investigated the role of IL-21R signaling using a series of in vivo experimentally induced disease models. We first addressed the role of IL-21R signaling in Th2 immune responses by examining allergic airway inflammation, Nippostrongylus brasiliensis and Heligomosomoides polygyrus anti-helminth responses. In each of these systems, IL-21R signaling played a clear role in the development of Th2 responses. Comparatively, IL-21R signaling was not required for the containment of Leishmania major infection, or the development of experimental autoimmune myocarditis, indicative of competent Th1 and Th17 responses, respectively. Adoptive transfer of T cells and analysis of IL-21R+/+:-/- chimera mice revealed that IL-21R-signaling was central to Th2 cell survival or migration to peripheral tissues. Overall, our data shows IL-21 plays a crucial role in supporting polarized Th2 responses in vivo, whilst appearing superfluous for Th1 and Th17 responses.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. R. Ramalingam, J. T. Pesce, M. M. Mentink-Kane, S. Madala, A. W. Cheever, M. R. Comeau, S. F. Ziegler, and T. A. Wynn
Regulation of Helminth-Induced Th2 Responses by Thymic Stromal Lymphopoietin
J. Immunol.,
May 15, 2009;
182(10):
6452 - 6459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Zaretsky, J. J. Taylor, I. L. King, F. A. Marshall, M. Mohrs, and E. J. Pearce
T follicular helper cells differentiate from Th2 cells in response to helminth antigens
J. Exp. Med.,
May 11, 2009;
206(5):
991 - 999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Eddahri, S. Denanglaire, F. Bureau, R. Spolski, W. J. Leonard, O. Leo, and F. Andris
Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities
Blood,
March 12, 2009;
113(11):
2426 - 2433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Heer, N. L. Harris, M. Kopf, and B. J. Marsland
CD4+ and CD8+ T Cells Exhibit Differential Requirements for CCR7-Mediated Antigen Transport during Influenza Infection
J. Immunol.,
November 15, 2008;
181(10):
6984 - 6994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Leonard, R. Zeng, and R. Spolski
Interleukin 21: a cytokine/cytokine receptor system that has come of age
J. Leukoc. Biol.,
August 1, 2008;
84(2):
348 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gangadharan, M. A. Hoeve, J. E. Allen, B. Ebrahimi, S. M. Rhind, B. M. Dutia, and A. A. Nash
Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages
J. Leukoc. Biol.,
July 1, 2008;
84(1):
50 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Coquet, S. Chakravarti, M. J. Smyth, and D. I. Godfrey
Cutting Edge: IL-21 Is Not Essential for Th17 Differentiation or Experimental Autoimmune Encephalomyelitis
J. Immunol.,
June 1, 2008;
180(11):
7097 - 7101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Clough, C. J. Wang, E. M. Schmidt, G. Booth, T. Z. Hou, G. A. Ryan, and L. S. K. Walker
Release from Regulatory T Cell-Mediated Suppression during the Onset of Tissue-Specific Autoimmunity Is Associated with Elevated IL-21
J. Immunol.,
April 15, 2008;
180(8):
5393 - 5401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Davis, K. Skak, M. J. Smyth, P. E.G. Kristjansen, D. M. Miller, and P. V. Sivakumar
Interleukin-21 Signaling: Functions in Cancer and Autoimmunity
Clin. Cancer Res.,
December 1, 2007;
13(23):
6926 - 6932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wei, A. Laurence, K. M. Elias, and J. J. O'Shea
IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent Manner
J. Biol. Chem.,
November 30, 2007;
282(48):
34605 - 34610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Onoda, M. Rahman, H. Nara, A. Araki, K. Makabe, K. Tsumoto, I. Kumagai, T. Kudo, N. Ishii, N. Tanaka, et al.
Human CD4+ central and effector memory T cells produce IL-21: effect on cytokine-driven proliferation of CD4+ T cell subsets
Int. Immunol.,
October 1, 2007;
19(10):
1191 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|